omeprazole sulfone has been researched along with cholest-5-ene-3,4-diol in 1 studies
| Studies (omeprazole sulfone) | Trials (omeprazole sulfone) | Recent Studies (post-2010) (omeprazole sulfone) | Studies (cholest-5-ene-3,4-diol) | Trials (cholest-5-ene-3,4-diol) | Recent Studies (post-2010) (cholest-5-ene-3,4-diol) |
|---|---|---|---|---|---|
| 50 | 12 | 17 | 94 | 16 | 77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aklillu, E; Aminy, A; Bijnsdorp, A; Diczfalusy, U; Engidawork, E; Gebeyehu, E | 1 |
1 other study(ies) available for omeprazole sulfone and cholest-5-ene-3,4-diol
| Article | Year |
|---|---|
Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.
Topics: Adult; Alleles; Black People; Cholesterol; Cytochrome P-450 CYP3A; Ethiopia; Female; Genetic Variation; Genotype; Humans; Hydroxycholesterols; Male; Omeprazole; Sex Factors; Young Adult | 2011 |